雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Drugs under Development (Neurology) Yoshiki Sekijima 1,2 1Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine 2Institute for Biomedical Sciences, Shinshu University Keyword: 開発途上の薬剤 , 脳神経内科 , 核酸医薬 , 遺伝子治療 , 抗体薬 , drugs under development , neurology , nucleic acid therapeutic , gene therapy , antibody therapeutic pp.427-432
Published Date 2023/5/1
DOI https://doi.org/10.11477/mf.1416202354
  • Abstract
  • Look Inside
  • Reference

Abstract

Neurological diseases, especially degenerative diseases, have been mainly treated symptomatically with small molecule drugs. In recent years, however, the development of antibody therapeutics, nucleic acid therapeutics, and gene therapies that selectively act on specific proteins, RNA, and DNA has been underway to identify disease-modifying drugs that improve disease outcomes by acting on the underlying pathogenic mechanisms of diseases. It is expected to enable disease-modifying therapy not only for neuroimmunological and functional diseases, but also for neurodegenerative diseases caused by loss of protein function and accumulation of abnormal proteins.


Copyright © 2023, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有